drugset / Trial / NCT00643656

Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal Lesion

NCT00643656 ↗

Phase 4 Completed 94 enrolled Air Liquide
RandomizedParallel-groupTriple-blindTreatment

Summary

A 50% nitrous oxide / 50% oxygen premix is administrated to the patient during the realization of liver biopsy in order to relax him and to reduce his pain during this painful medical treatment. This single investigator centre and national clinical trial is done blindly : half of patients will receive 50% nitrous oxide / 50% oxygen premix and half of them a placebo gas (mixture of 50% oxygen and 50% nitrogen). 94 patients will be included in this clinical protocol.

Timeline

Start
2007-10
Primary completion
2008-06
Completion
2008-12

Outcome

Met primary endpoint

paper was significantly better in the EMONO group than in the placebo group (Δ = 17.8 ± 25.5 mm vs 30.1 ± 32.6 mm; P = .045. PMID 21511500 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Kalinox Unknown — Inhaled

Indications

No indication recorded.